Adaptive Biotechnologies Corp vs Valero Energy Corporation — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Valero Energy Corporation trades at $323.92 (market cap $93.27B). The key difference: Valero Energy Corporation is far larger — about 23.1× Adaptive Biotechnologies Corp's market cap, and Valero Energy Corporation pays a 1.48% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | VLO | |
|---|---|---|
Market Cap | $4.04B | $93.27B |
Sector | Health | Energy |
52-Week High | $25.45 | $323.92 |
52-Week Low | $12.30 | $133.38 |
Enterprise Value | $4.10B | $96.74B |
Dividend Yield | — | 1.48% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →